000000_Synthonics_ChyloCureBook_Rev031919

2019 2020 2021 2022 2023 Net Sales $ 600,000 $ 2,039,400 $ 3,812,556 $ 7,127,383 $ 9,286,624 Cost of Goods $ 82,980 $ 290,510 $ 559,388 $ 1,077,120 $ 1,445,536

Gross Margins $ 517,020 $ 1,748,890 $ 3,253,168 $ 6,050,263 $ 7,841,088 Commissions $ 90,000 $ 305,910 $ 571,883 $ 1,069,107 $ 1,392,994 R&D $ 80,000 $ 100,000 $ 100,000 $ 100,000 $ 120,000 General and Admin $ 246,000 $ 270,000 $ 300,000 $ 450,000 $ 500,000

Operating Income $ 101,020 $ 1,072,980 $ 2,281,285 $ 4,431,156 $ 5,828,094 Capital Expenditures $ 425,000 $ 60,000 $ 120,000 $ 180,000 $ 18,000

Net Pre-Tax Cash Flow $ (323,980) $ 1,012,980 $ 2,161,285 $ 4,251,156 $ 5,810,094

Pro Forma Financials